恒瑞医药
(600276)
| 流通市值：3255.84亿 | | | 总市值：3255.84亿 |
| 流通股本：63.79亿 | | | 总股本：63.79亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 24,815,905,657.75 | 22,131,746,769.8 | 22,312,247,262.78 | 21,306,321,231.25 |
| 应收票据及应收账款 | 5,064,745,008.65 | 5,718,899,410.25 | 6,278,140,057.73 | 5,133,070,113.96 |
| 其中：应收票据 | 149,872,397.37 | 45,123,046.17 | 124,868,368.02 | 307,987,410.34 |
| 应收账款 | 4,914,872,611.28 | 5,673,776,364.08 | 6,153,271,689.71 | 4,825,082,703.62 |
| 应收款项融资 | 1,094,724,979.82 | 1,073,326,532.38 | 653,551,807.83 | 2,177,880,386.32 |
| 预付款项 | 1,147,239,443.44 | 1,664,834,473.02 | 1,521,748,554.1 | 1,424,698,761.35 |
| 其他应收款合计 | 66,413,247.5 | 130,652,978.76 | 390,463,642.05 | 528,545,481.51 |
| 存货 | 2,417,118,478.12 | 2,530,975,157.69 | 2,252,003,098.77 | 2,273,245,503.61 |
| 其他流动资产 | 435,435,740.94 | 432,812,829.64 | 395,253,472.13 | 402,076,947.54 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 35,314,927,240.59 | 34,456,969,388.16 | 34,776,635,798.26 | 33,712,251,970.65 |
| 非流动资产: | | | | |
| 长期股权投资 | 666,353,806.05 | 633,707,064.56 | 653,759,176.16 | 672,308,474.09 |
| 其他非流动金融资产 | 1,065,410,856.58 | 835,069,613.65 | 845,337,907.82 | 596,778,513.03 |
| 固定资产 | 5,131,973,616.64 | 5,152,206,131.84 | 5,392,863,743.45 | 5,450,816,165.7 |
| 在建工程 | 1,687,525,956.97 | 1,448,521,992.06 | 1,142,127,440.22 | 1,041,705,008.89 |
| 使用权资产 | 108,663,501.72 | 88,646,951.03 | 98,779,993.05 | 81,371,149.17 |
| 无形资产 | 1,192,307,211.5 | 1,165,402,422.01 | 861,905,050.7 | 871,856,459.98 |
| 开发支出 | 3,837,558,941.33 | 3,441,149,026.55 | 3,315,194,903.6 | 2,812,221,566.44 |
| 长期待摊费用 | 274,642,793.52 | 279,953,611.91 | 297,968,493.28 | 312,494,463.2 |
| 递延所得税资产 | 377,174,628.6 | 413,245,026.89 | 404,342,199.02 | 365,860,975.7 |
| 其他非流动资产 | 479,106,750.6 | 423,228,184.06 | 392,445,338.01 | 422,336,603.99 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 14,820,718,063.51 | 13,881,130,024.56 | 13,404,724,245.31 | 12,627,749,380.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 50,135,645,304.1 | 48,338,099,412.72 | 48,181,360,043.57 | 46,340,001,350.84 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 1,967,259,141.2 | 1,539,939,354.39 | 1,517,442,150.85 | 1,458,600,980.73 |
| 其中：应付票据 | - | - | 78,615,419.14 | 203,748,970.78 |
| 应付账款 | 1,967,259,141.2 | 1,539,939,354.39 | 1,438,826,731.71 | 1,254,852,009.95 |
| 合同负债 | 159,793,447.59 | 1,277,373,860.08 | 1,225,506,648.68 | 1,451,487,263.71 |
| 应付职工薪酬 | 4,921,404.37 | 3,313,358.14 | 2,061,796.79 | 658,288.26 |
| 应交税费 | 426,994,059.62 | 356,043,358.48 | 248,113,435.74 | 249,300,556.07 |
| 其他应付款合计 | 1,029,985,142.5 | 613,689,134.42 | 1,772,253,951.2 | 529,322,348.75 |
| 应付股利 | - | - | 1,273,768,320.8 | - |
| 一年内到期的非流动负债 | 41,125,925.62 | 36,275,492.24 | 36,743,938.68 | - |
| 其他流动负债 | 3,516,601.77 | 2,931,852.42 | 6,183,564.27 | 8,702,218.63 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,633,595,722.67 | 3,829,566,410.17 | 4,808,305,486.21 | 3,698,071,656.15 |
| 非流动负债: | | | | |
| 租赁负债 | 69,036,137.59 | 51,304,835.13 | 58,279,374.6 | 78,398,362.45 |
| 递延收益 | 225,650,466.9 | 42,550,000 | 42,550,000 | 38,950,000 |
| 递延所得税负债 | 117,112,243.63 | 83,159,472 | 85,089,026.78 | 85,226,030.16 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 411,798,848.12 | 177,014,307.13 | 185,918,401.38 | 202,574,392.61 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,045,394,570.79 | 4,006,580,717.3 | 4,994,223,887.59 | 3,900,646,048.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 6,379,002,274 | 6,379,002,274 | 6,379,002,274 | 6,379,002,274 |
| 资本公积 | 3,188,072,621.03 | 3,222,352,294.98 | 3,167,042,360.34 | 3,112,565,084.81 |
| 减:库存股 | 1,228,624,448.88 | 1,288,758,873.46 | 1,202,013,650.99 | 1,101,854,773.92 |
| 其他综合收益 | 16,970,393.77 | 7,823,246.29 | 18,549,717.98 | 13,180,620.38 |
| 盈余公积 | 3,298,912,011.55 | 3,298,912,011.55 | 3,298,912,011.55 | 3,298,912,011.55 |
| 未分配利润 | 33,865,529,008.85 | 32,148,577,868.39 | 30,960,750,092.2 | 30,171,699,562.75 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 45,519,861,860.32 | 43,767,908,821.75 | 42,622,242,805.08 | 41,873,504,779.57 |
| 少数股东权益 | 570,388,872.99 | 563,609,873.67 | 564,893,350.9 | 565,850,522.51 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 46,090,250,733.31 | 44,331,518,695.42 | 43,187,136,155.98 | 42,439,355,302.08 |
| 负债和股东权益合计 | 50,135,645,304.1 | 48,338,099,412.72 | 48,181,360,043.57 | 46,340,001,350.84 |
| 公告日期 | 2025-03-31 | 2024-10-25 | 2024-08-22 | 2024-04-18 |
| 审计意见(境内) | 标准无保留意见 | | | |